Market Price

104.80 

-0.05 -0.1%

as of Mar 20 '19

52 Week Range:

83.56 125.20


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

ORPEA Société Anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing care facilities provide personalized support services; and logistical and residential services, including accommodation, meals, laundry and room cleaning, and various daily entertainment and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, and psychosomatic conditions, as well as geriatric, child, young, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. As of May 2, 2018, it operated 818 facilities with 86,650 beds. The company operates in France, Belgium, Spain, Italy, Switzerland, Austria, Germany, the Czech Republic, Poland, and China. ORPEA Société Anonyme was founded in 1989 and is headquartered in Puteaux, France.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Equity (BVPS) 12.71
13.68
15.42
19.08
17.09
22.92
22.70
25.33
28.88
29.90
31.54
growth rate 7.6% 12.7% 23.7% -10.4% 34.1% -1.0% 11.6% 14.0% 3.5% 5.5%
Earnings BIT 57.70
64.20
91.00
97.27
125.82
148.49
227.28
271.24
303.52
348.07
394.35
growth rate 11.3% 41.7% 6.9% 29.4% 18.0% 53.1% 19.3% 11.9% 14.7% 13.3%
Avg.PE 36.00
25.80
20.08
22.12
14.77
19.69
21.19
31.36
34.81
36.90
45.10
growth rate -28.3% -22.2% 10.2% -33.2% 33.3% 7.6% 48.0% 11.0% 6.0% 22.2%
ROA 2.57
2.10
2.17
1.91
1.92
2.06
2.19
2.06
1.85
3.27
1.00
growth rate -18.3% 3.3% -12.0% 0.5% 7.3% 6.3% -5.9% -10.2% 76.8% -69.4%
ROE 10.83
9.29
10.34
8.81
7.96
8.20
8.67
8.30
7.66
13.20
3.75
growth rate -14.2% 11.3% -14.8% -9.7% 3.0% 5.7% -4.3% -7.7% 72.3% -71.6%
ROIC 6.37
5.13
4.13
4.94
4.15
3.88
4.36
4.16
3.57
5.81
2.21
growth rate -19.5% -19.5% 19.6% -16.0% -6.5% 12.4% -4.6% -14.2% 62.8% -62.0%
Cur. Ratio 0.39
0.41
0.46
0.66
0.61
0.55
0.73
0.83
0.94
0.90
1.05
growth rate 5.1% 12.2% 43.5% -7.6% -9.8% 32.7% 13.7% 13.3% -4.3% 16.7%
Quick Ratio 0.38
0.40
0.46
0.53
0.34
0.42
0.54
0.65
0.73
0.75
0.93
growth rate 5.3% 15.0% 15.2% -35.9% 23.5% 28.6% 20.4% 12.3% 2.7% 24.0%
Leverage 4.08
4.76
4.77
4.48
3.89
4.08
3.86
4.20
4.07
4.01
3.57
growth rate 16.7% 0.2% -6.1% -13.2% 4.9% -5.4% 8.8% -3.1% -1.5% -11.0%
Balance Sheet Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Acct.Receivable 69.74
76.50
228.00
260.00
226.00
252.60
311.07
448.49
525.36
635.28
growth rate 9.7% 198.0% 14.0% -13.1% 11.8% 23.2% 44.2% 17.1% 20.9%
Acct.Payable 144.00
172.00
155.00
201.24
235.56
255.27
233.22
228.25
growth rate 19.4% -9.9% 29.8% 17.1% 8.4% -8.6% -2.1%
Cur.Assets 223.54
391.40
647.00
725.00
726.00
948.15
1,157.11
1,201.95
1,244.33
1,371.82
growth rate 75.1% 65.3% 12.1% 0.1% 30.6% 22.0% 3.9% 3.5% 10.3%
Total Assets 2,571.87
3,061.20
3,880.00
4,482.00
4,955.00
5,451.59
6,286.19
7,371.32
8,375.02
9,695.48
growth rate 19.0% 26.8% 15.5% 10.6% 10.0% 15.3% 17.3% 13.6% 15.8%
Cash 53.65
135.40
277.00
309.00
362.00
468.35
621.91
518.93
539.92
613.90
growth rate 152.4% 104.6% 11.6% 17.2% 29.4% 32.8% -16.6% 4.1% 13.7%
Inventory 2.74
3.40
3.00
4.00
5.00
5.70
6.63
8.08
8.37
8.67
growth rate 24.1% -11.8% 33.3% 25.0% 13.9% 16.3% 21.9% 3.6% 3.6%
Cur.Liabilities 551.07
750.00
987.00
1,185.00
1,320.00
1,288.32
1,391.95
1,280.46
1,381.76
1,305.78
growth rate 36.1% 31.6% 20.1% 11.4% -2.4% 8.0% -8.0% 7.9% -5.5%
Liabilities 2,031.19
2,419.60
2,985.00
3,327.00
3,739.00
4,038.24
4,787.84
5,561.61
6,261.90
6,980.10
growth rate 19.1% 23.4% 11.5% 12.4% 8.0% 18.6% 16.2% 12.6% 11.5%
LT Debt 747.04
1,033.85
1,180.20
1,459.00
1,462.00
1,670.00
1,920.05
2,479.03
3,218.99
3,801.25
4,621.58
growth rate 38.4% 14.2% 23.6% 0.2% 14.2% 15.0% 29.1% 29.9% 18.1% 21.6%
Equity 500.56
540.68
641.90
894.60
1,154.50
1,215.80
1,412.37
1,497.97
1,809.52
2,112.92
2,715.17
growth rate 8.0% 18.7% 39.4% 29.1% 5.3% 16.2% 6.1% 20.8% 16.8% 28.5%
Common Shares 40.00
40.00
42.00
42.00
47.00
57.00
57.00
60.00
60.00
60.00
62.00
growth rate 0.0% 5.0% 0.0% 11.9% 21.3% 0.0% 5.3% 0.0% 0.0% 3.3%
Cash Flow Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Capital Expenditures 301.48
328.47
263.20
359.00
82.00
145.00
155.62
416.35
130.86
130.86
164.74
growth rate 9.0% -19.9% 36.4% -77.2% 76.8% 7.3% 167.6% -68.6% 0.0% 25.9%
Cash Dividends 0.00
0.00
3.70
5.80
9.70
26.50
31.80
38.83
44.45
54.25
60.53
growth rate 56.8% 67.2% 173.2% 20.0% 22.1% 14.5% 22.0% 11.6%
Cash From OA 87.96
100.18
130.70
136.00
202.00
208.00
247.28
290.14
313.94
346.71
397.90
growth rate 13.9% 30.5% 4.1% 48.5% 3.0% 18.9% 17.3% 8.2% 10.4% 14.8%
FCF per Share -1.40
-5.76
-3.81
-4.61
-5.46
1.47
2.23
4.57
4.89
5.59
6.19
growth rate 0.0% 0.0% 0.0% 0.0% 100.0% 51.7% 104.9% 7.0% 14.3% 10.7%
Sale Purchase of Stock 94.10
3.19
6.04
growth rate -96.6% 89.1%
FCF -56.00
-228.00
-159.00
-193.00
-153.00
84.00
247.00
290.00
314.00
347.00
398.00
growth rate 0.0% 0.0% 0.0% 0.0% 100.0% 194.1% 17.4% 8.3% 10.5% 14.7%
Income Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Sales 544.60
702.32
843.30
964.00
1,234.00
1,429.00
1,607.92
1,948.58
2,391.60
2,841.23
3,138.23
growth rate 29.0% 20.1% 14.3% 28.0% 15.8% 12.5% 21.2% 22.7% 18.8% 10.5%
Op.Income 106.89
134.50
66.00
80.00
97.00
227.28
271.24
303.52
348.07
394.35
growth rate 25.8% -50.9% 21.2% 21.3% 134.3% 19.3% 11.9% 14.7% 13.3%
IBT 64.20
91.00
97.30
125.00
148.50
174.80
186.45
186.60
298.54
143.08
growth rate 41.7% 6.9% 28.5% 18.8% 17.7% 6.7% 0.1% 60.0% -52.1%
Net Income 48.38
61.20
66.00
80.00
97.00
113.91
120.78
126.63
293.53
89.79
growth rate 26.5% 7.8% 21.2% 21.3% 17.4% 6.0% 4.9% 131.8% -69.4%
EPS 1.03
1.21
1.47
1.59
1.82
1.79
2.08
2.08
2.12
4.26
1.46
growth rate 17.5% 21.5% 8.2% 14.5% -1.7% 16.2% 0.0% 1.9% 100.9% -65.7%
Gross Profit 400.60
516.93
623.70
222.00
275.00
325.00
378.24
431.08
476.37
556.56
637.27
growth rate 29.0% 20.7% -64.4% 23.9% 18.2% 16.4% 14.0% 10.5% 16.8% 14.5%

Quarterly Statements

Item Name Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Earnings BIT 94.03
103.14
103.14
100.90
100.90
growth rate 9.7% 0.0% -2.2% 0.0%
Balance Sheet Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Acct.Receivable 444.97
635.28
635.28
710.42
710.42
growth rate 42.8% 0.0% 11.8% 0.0%
Acct.Payable 213.67
228.25
228.25
239.30
239.30
growth rate 6.8% 0.0% 4.8% 0.0%
Cur.Assets 1,353.16
1,371.82
1,371.82
1,631.00
1,631.00
growth rate 1.4% 0.0% 18.9% 0.0%
Total Assets 9,161.82
9,695.48
9,695.48
10,496.00
10,496.00
growth rate 5.8% 0.0% 8.3% 0.0%
Cash 554.47
613.90
613.90
822.00
822.00
growth rate 10.7% 0.0% 33.9% 0.0%
Inventory 10.73
8.67
8.67
9.42
9.42
growth rate -19.2% 0.0% 8.6% 0.0%
Cur.Liabilities 2,025.85
1,305.78
1,305.78
1,616.00
1,616.00
growth rate -35.5% 0.0% 23.8% 0.0%
Liabilities 7,126.76
6,980.10
6,980.10
7,747.00
7,747.00
growth rate -2.1% 0.0% 11.0% 0.0%
LT Debt 4,027.88
4,621.58
4,621.58
5,002.00
5,002.00
growth rate 14.7% 0.0% 8.2% 0.0%
Equity 2,034.84
2,715.17
2,715.17
2,749.00
2,749.00
growth rate 33.4% 0.0% 1.3% 0.0%
Common Shares 75.76
80.69
80.69
2,749.00
2,749.00
growth rate 6.5% 0.0% 3,306.8% 0.0%
Cash Flow Statement Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Capital Expenditures 49.51
32.86
32.86
150.63
150.63
growth rate -33.6% 0.0% 358.4% 0.0%
Cash Dividends 30.27
30.27
30.27
growth rate 0.0% 0.0%
Cash From OA 83.85
115.10
115.10
94.50
94.50
growth rate 37.3% 0.0% -17.9% 0.0%
FCF 34.34
82.24
82.24
-56.13
-56.13
growth rate 139.5% 0.0% -100.0% 0.0%
Income Statement Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Sales 762.86
806.26
806.26
839.50
839.50
growth rate 5.7% 0.0% 4.1% 0.0%
Op.Income 94.03
103.14
103.14
100.90
100.90
growth rate 9.7% 0.0% -2.2% 0.0%
IBT 10.46
61.09
61.09
78.30
78.30
growth rate 484.2% 0.0% 28.2% 0.0%
Net Income -20.88
65.77
65.77
53.80
53.80
growth rate 100.0% 0.0% -18.2% 0.0%
Gross Profit 153.65
164.99
164.99
172.60
172.60
growth rate 7.4% 0.0% 4.6% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (62.20)

YOY Growth Grade:

B (67.86)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 27.94 27.86 25.82
EPS / Growth 12.4% 3.76 16.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 19.8%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 12.4% 16.1% 16.1%
Future PE 24.82 28.67 28.67
Future EPS 12.12 16.76 16.76
Value Price
MOS %
74.33
-29.1%
118.79
13.4%
118.79
13.4%
MOS Price 37.17 59.40 59.40
IRT 12.01 10.57 10.57

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.